Trial Profile
An Advanced Echocardiographic Evaluation of Nebivolol.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 24 Nov 2015 According to ClinicalTrials.gov record the study design has been changed from Parallel assignment to Single Group.
- 01 Aug 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.